Premium
THE EVALUATION OF MTOR PATHWAY DYSREGULATION AS A NOVEL BLOOD‐BASED PHENOTYPIC RISK BIOMARKER FOR THE ASSESSMENT OF ALZHEIMER'S DISEASE AND DEMENTIA
Author(s) -
Hampel Harald Juergen,
Dubois Bruno,
McKeith Ian,
O'Brien John,
Lopez Oscar,
Hansson Oskar,
Pither Richard,
Vandenberghe Rik,
Lista Simone
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.04.462
Subject(s) - dementia , disease , biomarker , medicine , pi3k/akt/mtor pathway , bioinformatics , cognitive decline , clinical trial , neuroscience , oncology , psychology , signal transduction , biology , genetics